The enthusiasm, discussed in your Opinion article "Towards a 'knowledge nation'" (Nature 411, 619; 2001), for commercialization of Australian basic scientific research, and the call for more ...

The previous chapter provided descriptive evidence around the landscape of SBIR/STTR winners. This report now turns to the observable impact of the DOE SBIR/STTR programs on key dimensions of ...

With so many variables impacting the commercialization process, we pulled together some examples of how firms successfully bring new products to market. There are plenty of difficult tasks when ...

This article explores the steps taken to commercializing flexible hybrid electronics, including an example of an FHE solution that has already come on to the market. The starting point for roadmaps ...

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora discusses ways that cell and gene therapy developers can follow examples from the ...

In thinking about the economics around the launch of pharmaceutical products, it is useful to compare the situation to another area that has seen its economics evolve in recent years: space travel.